Heterodimeric, bispecific, and multivalent antibodies; nucleic acid and expression vector compositions; host cell; methods for producing a heterodimeric antibody, a multivalent antibody, and for treating a TROP2-associated cancer in a patient in need; and TROP2-binding construct.

BR112025022172A2Pending Publication Date: 2026-09-08
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
BR112025022172
Authority / Receiving Office
BR · BR
Patent Type
Applications
Publication Date
2026-09-08

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.